Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
FDA approves Wegovy pill for weight loss: What to know - 2Rocket Lab launches mystery satellite for 'confidential commercial customer' (video)
- 3CDC studies show value of nationwide wastewater disease surveillance, as potential funding cut looms
- 4Top notch Remote Earphones for Audiophiles
- 5Move. Cheer. Dance. Do the wave. How to tap into the collective joy of 'we mode'
- A definitive Bike Standoff: Decision in favor of Your Number one Ride
- IDF destroys Hamas shaft in northern Gaza with loaded 'ready to fire' rocket aimed at Sderot
- Car Investigation: A Survey of \Past the Outside\ Car
- Germany raises prospect of military forces to secure Ukraine peace
- Iran warns its ready to open new front in Yemen, close Bab al-Mandab Strait with Houthis
- Several killed in Ukraine and Russia after cross-border attacks
- UN chief calls on Yemen's Houthi rebels to free all UN detainees
- Fake new headlights rule steer Australian drivers astray
- Revealing the Incomparable Realms: An Excursion through Power and Inheritance
